Please login to the form below

Not currently logged in
Email:
Password:

Esteve appoints Albert Esteve as chairman of the board of directors

He succeeds Joan Esteve, who continues as chairman of the general shareholders meeting

Spanish pharmaceutical group Esteve has appointed Albert Esteve as its chairman of the board of directors to replace Joan Esteve, who will continue serving the group as chairman of the general shareholders meeting.

Albert Esteve joined the group as an assistant to general management and was appointed member of the group’s executive committee and has been chief executive officer since 2011.

Additionally, Staffan Schuberg will join as chief executive officer, effective January 2018, following more than 20 years’ experience from pharmaceutical companies such as Lundbeck, where he held the position of executive vice president and chief commercial officer.

Esteve said: “This is a new challenge that I am facing with tremendous enthusiasm.

“Regarding the CEO appointment, we feel fortunate and are much honoured to welcome Staffan Schuberg as the new executive leader of the group.”

3rd November 2017

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Innovative Trials

Innovative Trials specialises in delivering effective global patient recruitment strategies for your clinical trials by adopting a patient and site-centric...

Latest intelligence

Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...